Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Jaydeep Srimani, PhD, BS
Director, Quantitative Clinical Pharmacology
Takeda Development Center Americas, Inc.
Poster(s):
070: Population Pharmacokinetic & Exposure-Response Analyses for the Phase 3 PhALLCON Study of Ponatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
